With Strong Q3 Financials, Pfizer Says It's Ready For Generic Competition To Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
The world's largest pharma highlights sales growth of Prevnar 13, Enbrel and Lyrica, emerging markets growth, and a developing plan to sell off animal health and nutritional units.